Novozymes A/S (NVZMY)
OTCMKTS · Delayed Price · Currency is USD
63.31
-0.51 (-0.80%)
Sep 10, 2025, 3:45 PM EDT
Novozymes Revenue
Novozymes had revenue of 1.02B EUR in the quarter ending June 30, 2025, with 4.12% growth. This brings the company's revenue in the last twelve months to 4.10B, up 34.50% year-over-year. In the year 2024, Novozymes had annual revenue of 3.83B with 59.58% growth.
Revenue (ttm)
4.10B EUR
Revenue Growth
+34.50%
P/S Ratio
6.18
Revenue / Employee
387.25K EUR
Employees
10,582
Market Cap
29.76B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
Dec 31, 2023 | 2.40B | 42.38M | 1.80% |
Dec 31, 2022 | 2.36B | 348.99M | 17.36% |
Dec 31, 2021 | 2.01B | 128.32M | 6.82% |
Dec 31, 2020 | 1.88B | -41.10M | -2.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 252.15M |
Panamera Holdings | 212.04K |
Rubber Leaf | 2.02M |
Cardinal Ethanol, LLC | 350.34M |
Xtra Energy | 559.33K |
Novozymes News
- 20 days ago - Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Novozymes A/S 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 20 days ago - Novonesis CEO: Maintaining margins despite macroeconomic headwinds - CNBC
- 20 days ago - Novozymes A/S Non-GAAP EPS of €0.78, revenue of €2.09B - Seeking Alpha
- 3 months ago - Novonesis: Industry Leader With Defensive Characteristics And Solid Growth - Seeking Alpha
- 4 months ago - Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Novo Nordisk Stakeholder Reports $9 Billion In Income Due To Robust Weight Loss Drug Sales - Benzinga
- 5 months ago - Tariffs create uncertainty and pause investment, says Novonesis CEO - CNBC